Posted Jul. 13, 2017 at 10:35 a.m.

Premium Lock G1 Therapeutics names former GSK top exec Andrew Witty to board

Published: 2017-07-13 10:35:18
Updated: 2017-07-13 10:35:18

Andrew Witty          Andrew Witty. (GSK photo)

Andrew Witty, formerly CEO of drug giant GlaxoSmithKline, is now a member of the board of directors at RTP-based G1 Therapeutics....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders